Chicago Equity Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $810K | Sell |
2,310
-100
| -4% | -$35.1K | 0.08% | 321 |
|
|
2019
Q4 | $892K | Sell |
2,410
-1,300
| -35% | -$481K | 0.05% | 484 |
|
|
2019
Q3 | $1.23M | Sell |
3,710
-50
| -1% | -$16.6K | 0.06% | 435 |
|
|
2019
Q2 | $1.18M | Buy |
3,760
+1,660
| +79% | +$519K | 0.05% | 483 |
|
|
2019
Q1 | $642K | Buy |
2,100
+510
| +32% | +$156K | 0.02% | 617 |
|
|
2018
Q4 | $369K | Buy |
+1,590
| New | +$369K | 0.01% | 685 |
|
|
2018
Q3 | – | Sell |
-4,150
| Closed | -$1.2M | – | 802 |
|
|
2018
Q2 | $1.2M | Buy |
4,150
+275
| +7% | +$79.3K | 0.04% | 490 |
|
|
2018
Q1 | $969K | Hold |
3,875
| – | – | 0.03% | 510 |
|
|
2017
Q4 | $925K | Buy |
3,875
+2,020
| +109% | +$482K | 0.03% | 516 |
|
|
2017
Q3 | $412K | Sell |
1,855
-2,845
| -61% | -$632K | 0.01% | 647 |
|
|
2017
Q2 | $1.06M | Buy |
+4,700
| New | +$1.06M | 0.03% | 498 |
|
|
2016
Q1 | – | Sell |
-13,305
| Closed | -$1.85M | – | 587 |
|
|
2015
Q4 | $1.85M | Sell |
13,305
-6,385
| -32% | -$885K | 0.05% | 267 |
|
|
2015
Q3 | $2.65M | Buy |
19,690
+195
| +1% | +$26.2K | 0.07% | 220 |
|
|
2015
Q2 | $2.94M | Buy |
+19,495
| New | +$2.94M | 0.08% | 177 |
|